• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Miracor

FDA grants breakthrough nod to Miracor Medical’s PiCSO device

August 22, 2019 By Sean Whooley

Miracor Medical said today that it received breakthrough designation from the FDA for its PiCSO device for treating a type of heart attack. The PiCSO (pressure-controlled intermittent coronary sinus occlusion) system is designed to clear coronary microcirculation by intermittently stopping the delivery of blood through the coronary sinus into the right atrium. The intended result […]

Filed Under: Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA) Tagged With: Miracor

Miracor Medical closes $35m Series D

September 4, 2018 By Fink Densford

Miracor Medical Systems said today it raised $34.6 million (EU €30 million) Series D round of financing to help support the development and commercialization of its PiCSO Impulse System. The round was led by Ming Capital and co-led by a strategic investor, the Belgium-based company said. The round was also joined by newly invested Belgian […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup Tagged With: Miracor

Miracor closes $30m Series D

January 4, 2018 By Fink Densford

Miracor Medical Systems said today it closed a $30.2 million (EU €25 million) round of funding as part of Series D financing round with funds slated to support further development and commercialization of its PiCSO impulse system, and announced it is moving its headquarters from Austria to Belgium. The company’s PiCSO therapy is designed to […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: Miracor

Zimmer & Biomet shift personnel after acquisition| Personnel Moves

June 30, 2015 By Fink Densford

Zimmer (NYSE:ZMH), who acquired Biomet in a deal that closed this month, announced a series of personnel shifts upon the closure of the merger. Zimmer CFO and senior veep James Crines has stepped down from his position to retire, effective August 3, to be replaced by former CFO and senior veep of BiometDaniel Florin, the company said. […]

Filed Under: Business/Financial News Tagged With: Biomet, Boston Scientific, Cantel Medical Corp., Cochlear Ltd., DynoSense, InVivo Therapeutics, Miracor, Nevro Corp., Orthofix, second-sight-medical, Transgenomic Inc., Zimmer Biomet

Miracor expands in the U.K.

April 2, 2015 By Mark Hollmer Leave a Comment

Miracor expands in the U.K.

Austria’s Miracor Medical Systems is boosting its presence in the U.K. with a new sales office and 2 clinical trials of its heart attack-treatment device.

Filed Under: Cardiovascular, News Well Tagged With: Clinical Trials, Miracor

Miracor’s coronary sinus occlusion system treats 1st patient in U.K.

December 26, 2012 By MassDevice staff Leave a Comment

Miracor Medical Systems logo

Private medical device maker Miracor Medical Systems GmbH won CE Mark approval for its Pressure-controlled Intermittent Coronary Sinus Occlusion System.

In conjunction with the regulatory win, the company announced that it successfully treated its 1st patient, a U.K. woman who suffered a large acute heart attack.

Filed Under: Blood Management, News Well Tagged With: Miracor

Diabetes: Treatment by variety | MassDevice.com On Call

July 10, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Standardization is no longer the key to diabetes treatment, according to new guidelines published in the journal Diabetes Care.

Doctors should steer away from encouraging all diabetes patients toward achieving universal blood sugar levels and offer personalized goals based on a patient’s age, overall health and lifestyles preferences.

Filed Under: Healthcare Reform, News Well Tagged With: Centers for Medicare and Medicaid Services (CMS), Miracor, On Call

Edwards to re-state financials | Wall Street Beat

February 28, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Edwards Lifesciences (NYSE:EW) said it will re-state its financial results for the first 3 quarters of 2011, “due to certain technical errors in the balance sheets and cash flow statements for these interim periods.”

The Irvine, Calif.-based heart valve maker said the errors involve the mis-statement of short-term investments as cash & equivalents, plus the way it treated tax benefits from stock plans.

Filed Under: News Well, Wall Street Beat Tagged With: AtriCure Inc., Biolase, CareFusion Corp., Deals Roundup, Dehaier Medical Systems Ltd., Edwards Lifesciences, Freedom Medical, Henry Schein Inc., InfuSystem, Intuitive Surgical, LeMaitre Vascular Inc., Miracor, Nihon Kohden, NxStage Medical Inc., Volcano Corp., wrightmedical

Miracor secures $10 million in series B

September 14, 2011 By MassDevice Contributors Network Leave a Comment

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Miracor, Venture Capital/Private Equity

Miracor secures $10 million in series B | Funding Roundup

September 14, 2011 By MassDevice staff Leave a Comment

Miracor

Private medical device company, Miracor Medical Systems GmbH, secured $10 million in the first closing of the series B financing round. Second closing is pending approval by investors.

Austria Wirtschaftsservice and German venture capital investment group SHS Gesellschaft für Beteiligungsmanagement joined existing investors, Earlybird and Delta Partners, to support Miracor’s financing round.

Filed Under: News Well, Wall Street Beat Tagged With: dextera, Miracor, Regulatory Roundup, Valeritas

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy